(Q38075493)

28 August 2017

1 reference

title

A systematic review of the cost effectiveness of herpes zoster vaccination (English)

1 reference

28 August 2017

1 reference

1 reference

Thomas D Szucs

1

1 reference

28 August 2017

Alena M Pfeil

series ordinal

2

1 reference

28 August 2017

publication date

1 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

31

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

125-136

1 reference

Herpes zoster and postherpetic neuralgia: past, present and future

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

In the clinic. Herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Herpes zoster: Burden of disease in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Herpes zoster in Germany: quantifying the burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Pain and its persistence in herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

[Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Economic evaluations of varicella vaccination programmes: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Prevention strategies for herpes zoster and post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Vaccination against Herpes Zoster and Postherpetic Neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Cost effectiveness of herpes zoster vaccine in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

An integrated evidence rating to frame comparative effectiveness assessments for decision makers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-012-0020-7

A Prospective Study of the Herpes Zoster Severity of Illness

21 January 2018

1 reference

12 December 2020

Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources

1 reference

12 December 2020

Examining the value and quality of health economic analyses: implications of utilizing the QHES.

1 reference

12 December 2020

Management and prevention of herpes zoster: A Canadian perspective

1 reference

12 December 2020

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

12 December 2020

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia

1 reference

12 December 2020

National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine

1 reference

12 December 2020

10.1007/S40273-012-0020-7

Identifiers

DOI

1 reference

release_jzo3zlvhtfeglni3zhg5wkfgra

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jzo3zlvhtfeglni3zhg5wkfgra

24 November 2022

mapped directly with Wikidata item

1 reference